A Phase II Study of Intratumoral Injection PF-3512676 in Combination With Local Radiation in Low-Grade B-Cell Lymphomas.
Phase of Trial: Phase II
Latest Information Update: 16 Mar 2017
At a glance
- Drugs Agatolimod (Primary)
- Indications B cell lymphoma
- Focus Therapeutic Use
- 02 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 02 Jan 2013 Planned end date changed from 1 Sep 2012 to 1 Sep 2013 as reported by ClinicalTrials.gov.
- 21 May 2010 Planned end date changed from 1 Dec 2011 to 1 Sep 2012 as reported by ClinicalTrials.gov.